Pages
Updated plans for Belper’s proposed new base for community health services to be shared on 27 January
Revised plans for a new base for Belper’s community health services, situated on the site of the former Belper Clinic, will be shared during a virtual meeting on Thursday 27 January at 6pm.
Accessibility Statement
Accessibility statement for www.dchs.nhs.uk
Health Psychology for Professionals
The information here is for professionals in Derbyshire seeking more information on the Health Psychology service.
Bakewell integrated health hub construction update - December 2022
https://dchs.nhs.uk/news/bakewell-integrated-health-hub-construction-update-december-2022
Derbyshire NHS Trust’s annual public accountability meeting - Open to all online
https://dchs.nhs.uk/news/derbyshire-nhs-trusts-annual-public-accountability-meeting-open-all-online
Tier 3 Weight Management - Information for Patients
Information for patients about the Tier 3 Weight Management service in Derbyshire.
Files
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024
8 Steps to Patient Isolation (L343)
Guidance to support colleagues when deciding how to isolate a patient with suspected/confirmed infection.